• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Colonic byproduct may decrease long-term weight gain

byAdarsh ManjunathandRavi Shah
December 13, 2014
in Chronic Disease, Gastroenterology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Propionate, a product of dietary fiber fermentation by colonic microbiota, was found to increase levels of peptide YY (PYY) and glucagon like peptide-1 (GLP-1) in humans, which regulate satiety in the brain.

2. Long-term supplementation with propionate prevented weight gain and reduced intra-abdominal fat accretion.

Evidence Rating Level: 2 (Good)

Study Rundown: Increasing evidence suggests that diet, gut microbiota, fat storage, and neurohormonal signaling all play major roles in appetite regulation and the development of obesity. Animal studies have revealed that the microbial fermentation of dietary fiber in the colon produces short chain fatty acids, such as propionate, which stimulate the release of gut hormones like PYY and GLP-1. These hormones are known to relay satiety to the appetite centers of the brain. Thus, the purpose of this study was to determine whether propionate would stimulate gut hormone release in the human colon and whether this would decrease appetite and prevent long-term weight gain in humans. In human colonic cell lines in vitro, propionate indeed increased both PYY and GLP-1 levels. A similar effect was seen when patients were provided with a form of oral propionate, and this translated into a nearly 14% reduction in food intake. Furthermore, compared to patients who took a placebo, patients who consumed the oral propionate long-term for 24 weeks had decreased weight gain (0% vs. 17% with >5% weight gain above baseline), decreased intra-abdominal adipose tissue distribution, and a trend towards reduced intrahepatocellular lipid (IHCL) content. Interestingly while weight gain prevention was maintained, PYY and GLP-1 levels did not remain elevated in the long-term group.

While previous studies on this subject were conducted in animal models, this study directly looked at propionate’s effects in humans. Additionally, the long-term results were compared to a control group that consumed an identical compound to the study group but without propionate, allowing for us to reason that the results can be attributed to propionate’s effects alone. However, this study only investigated weight gain over a period of 24 weeks and could not report whether body weight was maintained even after the study period. Thus, additional studies are necessary to determine the more long-lasting effects of propionate. Overall, this study suggests that even in humans, propionate may increase gut hormone levels and impact satiety to prevent long-term weight gain, making its use a potential tool in weight management strategies.

Click to read the study in Gut

RELATED REPORTS

Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

Relevant Reading: The gut microbiota and obesity: from correlation to causality

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [cell study, randomized controlled study]: This study was the first to determine propionate’s effects on weight gain in humans. The participants were of both genders, aged between 40-65 years, free of significant clinical disease, and without a recent drastic weight loss and were randomly assigned to the control or study group. First, it was found that propionate at a concentration of 400 mmol/L increased PYY and GLP-1 secretion from human colonic cells in vitro by up to 3-fold (p<0.001) and 2.4-fold (p<0.001), respectively. The authors manufactured an inulin-propionate ester, an orally ingested substance found to result in a 2.5-fold increase in daily propionate production by the colon. Using this substance, food intake was reduced in 20 volunteers by 13.8%, from 1175 kcal (CI95% 957 to 1392) to 1013 kcal (CI95% 816 to 1210), and plasma PYY and GLP-1 levels were increased compared to controls that consumed an inulin-control substance (p<0.05 for both). In a group of 60 volunteers who were randomized to consume the inulin-propionate ester or inulin-control for 24 weeks, the inulin-propionate ester group was found to have decreased weight gain (0% vs. 17% with >5% weight gain above baseline, p=0.033). Furthermore, the study group had a decreased change in distribution of intra-abdominal adipose tissue compared to the control group at the end of 24 weeks (p=0.027). Finally, the study group had a trend for reduced IHCL content (p=0.061), and interestingly, in volunteers who met the diagnostic criteria for non-alcoholic fatty liver disease, there was a significant reduction in IHCL content after inulin-propionate ester supplementation (22.1% (CI95% 7.7 to 36.6) vs. 15.9% (CI95% 5.2 to 26.5), p=0.038.

More from this author: Men who pay for sex at higher risk of acquiring STIs, Milk consumption paradoxically linked to increased risk of fractures and mortality, Incidence of esophageal cancer subtypes vary drastically globally and by gender, Modest alcohol consumption liked to poorer semen quality, Minimum unit pricing may be an effective alcohol control policy in the UK

Image: PD/Wiki/NCI

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: BMInutritionobesity
Previous Post

Injectable loaded microparticle scaffolds improve vaccine responses in mice [PreClinical]

Next Post

Medical comorbidities associated with poor semen quality

RelatedReports

Comparison of two types of bariatric surgery: a sleeve gastrectomy represented by a drawn stomach outline and a gastric band represented by a stomach with a band.
Chronic Disease

Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort

November 18, 2026
A collection of pharmaceutical items including a blister pack of tablets, a pen-like device, and several blank labels or strips, suggesting medication for obesity management.
2MM Trial Briefs

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

November 17, 2026
Knee osteoarthritis collage: a calm older man with a gray beard, a knee joint inset with teal cartilage and a knee brace
Endocrinology

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

November 17, 2026
Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Chronic Disease

Obesity associated with higher early-onset cancer risk among young Korean adults

November 13, 2026
Next Post

Medical comorbidities associated with poor semen quality

Preeclampsia linked to autism and developmental delay

Anaerobic antibiotics may decrease mortality in infants with necrotizing enterocolitis

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states
  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
  • Gait analysis predicts health, sleep, and medication use across 18 body systems
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.